XML 53 R37.htm IDEA: XBRL DOCUMENT v3.21.2
Revenue from Contracts with Customers - Schedule of Manufacturing and Royalty Revenues (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Disaggregation Of Revenue [Line Items]        
Total revenues $ 303,717 $ 247,529 $ 555,147 $ 493,749
Manufacturing Revenue        
Disaggregation Of Revenue [Line Items]        
Total revenues 29,293 25,341 54,378 65,552
Manufacturing Revenue | VUMERITY        
Disaggregation Of Revenue [Line Items]        
Total revenues 6,724 1,305 9,172 2,632
Manufacturing Revenue | RISPERDAL CONSTA        
Disaggregation Of Revenue [Line Items]        
Total revenues 12,003 10,193 22,686 33,776
Manufacturing Revenue | AMPYRA/FAMPYRA        
Disaggregation Of Revenue [Line Items]        
Total revenues 7,549 7,154 15,627 14,976
Manufacturing Revenue | Other        
Disaggregation Of Revenue [Line Items]        
Total revenues 3,017 6,689 6,893 14,168
Royalty        
Disaggregation Of Revenue [Line Items]        
Total revenues 113,001 91,164 207,763 167,204
Royalty | INVEGA SUSTENNA/XEPLION & INVEGA TRINZA/TREVICTA        
Disaggregation Of Revenue [Line Items]        
Total revenues 81,072 69,385 142,642 124,312
Royalty | VUMERITY        
Disaggregation Of Revenue [Line Items]        
Total revenues 13,624 1,289 24,616 1,654
Royalty | RISPERDAL CONSTA        
Disaggregation Of Revenue [Line Items]        
Total revenues 2,448 3,536 5,927 7,269
Royalty | AMPYRA/FAMPYRA        
Disaggregation Of Revenue [Line Items]        
Total revenues 5,767 5,354 12,361 12,501
Royalty | Other        
Disaggregation Of Revenue [Line Items]        
Total revenues 10,090 11,600 22,217 21,468
Manufacturing and royalty revenues        
Disaggregation Of Revenue [Line Items]        
Total revenues 142,294 116,505 262,141 232,756
Manufacturing and royalty revenues | INVEGA SUSTENNA/XEPLION & INVEGA TRINZA/TREVICTA        
Disaggregation Of Revenue [Line Items]        
Total revenues 81,072 69,385 142,642 124,312
Manufacturing and royalty revenues | VUMERITY        
Disaggregation Of Revenue [Line Items]        
Total revenues 20,348 2,594 33,788 4,286
Manufacturing and royalty revenues | RISPERDAL CONSTA        
Disaggregation Of Revenue [Line Items]        
Total revenues 14,451 13,729 28,613 41,045
Manufacturing and royalty revenues | AMPYRA/FAMPYRA        
Disaggregation Of Revenue [Line Items]        
Total revenues 13,316 12,508 27,988 27,477
Manufacturing and royalty revenues | Other        
Disaggregation Of Revenue [Line Items]        
Total revenues $ 13,107 $ 18,289 $ 29,110 $ 35,636